Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of <i>HER2</i>-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study
PaperCitations, authors & open-access status
Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of <i>HER2</i>-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 627 citations, 2014 year and green oa status.
627
Citations
2014
Year
green
OA Status